A Randomized Comparison of Long-Term Healing Between Biodegradable- Versus Durable-Polymer Everolimus Eluting Stents in STEMI

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 240 participants.

Also called NCT03440801

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 240 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03440801
Other papers using this trial's data
  • Low-Density Lipoprotein Cholesterol Levels and Neoatherosclerosis After STEMI: A Secondary Analysis of the CONNECT Randomized Clinical Trial JAMA cardiology, 2026-02-01 DOI, PubMed 41405905, PMC12712828 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03440801. Randomized; no masking; primary purpose treatment. Start 2017-07-03 (actual); primary completion 2024-07-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Randomized Comparison of Long-Term Healing Between Biodegradable- Versus Durable-Polymer Everolimus Eluting Stents in STEMI
Acronym
CONNECT
Condition
STEMI - ST Elevation Myocardial Infarction
Intervention (Device)
Synergy
Intervention (Device)
Xience
Lead sponsor
Tokorozawa Heart Center (class: other)
Collaborator
Insel Gruppe AG, University Hospital Bern (class: other)

Record details

Record id
cardio:ct-nct03440801
Content hash
74aeca4d62b6e75dd140c273061599b2891ca73acb1e1f2dd28c37d590643842